Macquarie Group LTD Heska Corp Transaction History

Macquarie Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$72.92 - $99.73 $9,042 - $12,366	-124 Closed	0 $9,000
Q4 2021 Feb 11, 2022	SELL	$156.0 - $265.78 $19,032 - $32,425	-122 Reduced 49.59%	124 $23,000
Q1 2021 May 14, 2021	BUY	$143.93 - $207.3 $17,703 - $25,497	123 Added 100.0%	246 $41,000
Q2 2020 Aug 11, 2020	BUY	$52.17 - $95.63 $6,416 - $11,762	123 New	123 $11,000
Q1 2019 May 15, 2019	SELL	$77.0 - $99.34 $199,584 - $257,489	-2,592 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$83.85 - $110.34 $12,325 - $16,219	-147 Reduced 5.37%	2,592 $223,000
Q3 2018 Nov 15, 2018	BUY	$97.14 - $113.31 $47,210 - $55,068	486 Added 21.57%	2,739 $310,000
Q2 2018 Aug 14, 2018	BUY	$74.5 - $108.91 $167,848 - $245,374	2,253 New	2,253 $234,000

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.